Last 12 months
Inside the activity.
0 purchase rows · 93 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 16 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 49 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 27, 2006 Filed Dec 28, 2006 17:34 UTC |
ALAM JOHN JSVP, Drug Eval. & Appr.
|
Exercise / conversionStock Options · Derivative | 500 | $0.00 Strike: $9.07 | $0.00 |
DisclosureSEC source: 0000875320-06-000127 · edgar.xml · derivative · entry 7 ALAM JOHN J · CIK 0001197014 · SVP, Drug Eval. & Appr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 498,495 Underlying: Common Stock · 500 shares Expires 2013-12-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting quarterly over 4 years from 12/11/2003. Read SEC document |
| December 27, 2006 Filed Dec 28, 2006 17:34 UTC |
ALAM JOHN JSVP, Drug Eval. & Appr.
|
Exercise / conversionStock Options · Derivative | 1,000 | $0.00 Strike: $18.47 | $0.00 |
DisclosureSEC source: 0000875320-06-000127 · edgar.xml · derivative · entry 6 ALAM JOHN J · CIK 0001197014 · SVP, Drug Eval. & Appr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 498,995 Underlying: Common Stock · 1,000 shares Expires 2007-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting quarterly over 5 years from 9/26/1997. Read SEC document |
| December 27, 2006 Filed Dec 28, 2006 17:34 UTC |
ALAM JOHN JSVP, Drug Eval. & Appr.
|
SaleCommon Stock | 500 | $37.56 | $18,780.00 |
DisclosureSEC source: 0000875320-06-000127 · edgar.xml · nonDerivative · entry 4 ALAM JOHN J · CIK 0001197014 · SVP, Drug Eval. & Appr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,376 F1 · kind: Transaction made pursuant to Dr. Alam's company approved trading plan established under rule 10b5-1. Read SEC document |
| December 27, 2006 Filed Dec 28, 2006 17:34 UTC |
ALAM JOHN JSVP, Drug Eval. & Appr.
|
SaleCommon Stock | 1,000 | $37.56 | $37,560.00 |
DisclosureSEC source: 0000875320-06-000127 · edgar.xml · nonDerivative · entry 3 ALAM JOHN J · CIK 0001197014 · SVP, Drug Eval. & Appr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,876 F1 · kind: Transaction made pursuant to Dr. Alam's company approved trading plan established under rule 10b5-1. Read SEC document |
| December 27, 2006 Filed Dec 28, 2006 17:34 UTC |
ALAM JOHN JSVP, Drug Eval. & Appr.
|
Exercise / conversionCommon Stock | 500 | $9.07 | $4,535.00 |
DisclosureSEC source: 0000875320-06-000127 · edgar.xml · nonDerivative · entry 2 ALAM JOHN J · CIK 0001197014 · SVP, Drug Eval. & Appr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,876 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 27, 2006 Filed Dec 28, 2006 17:34 UTC |
ALAM JOHN JSVP, Drug Eval. & Appr.
|
Exercise / conversionCommon Stock | 1,000 | $18.47 | $18,470.00 |
DisclosureSEC source: 0000875320-06-000127 · edgar.xml · nonDerivative · entry 1 ALAM JOHN J · CIK 0001197014 · SVP, Drug Eval. & Appr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,376 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 26, 2006 Filed Dec 27, 2006 18:57 UTC |
POWER JOHANNA MESSINAVP & Controller
|
Exercise / conversionCommon Stock · Derivative | 125 | $0.00 Strike: $9.69 | $0.00 |
DisclosureSEC source: 0000875320-06-000126 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,460 Underlying: Common Stock · 125 shares Expires 2014-03-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 20 equal quarterly installments from 3/17/2004. Read SEC document |
| December 26, 2006 Filed Dec 27, 2006 18:57 UTC |
POWER JOHANNA MESSINAVP & Controller
|
SaleCommon Stock | 125 | $37.25 | $4,656.25 |
DisclosureSEC source: 0000875320-06-000126 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,287 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| December 26, 2006 Filed Dec 27, 2006 18:57 UTC |
POWER JOHANNA MESSINAVP & Controller
|
Exercise / conversionCommon Stock | 125 | $9.69 | $1,211.25 |
DisclosureSEC source: 0000875320-06-000126 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,412 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 22, 2006 Filed Dec 27, 2006 18:53 UTC |
GARRISON RICHARD CSVP, Catalyst
|
SaleCommon Stock | 1,975 | $37.56 | $74,181.00 |
DisclosureSEC source: 0000875320-06-000125 · edgar.xml · nonDerivative · entry 1 GARRISON RICHARD C · CIK 0001256466 · SVP, Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,208 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Read SEC document |
| December 20, 2006 Filed Dec 21, 2006 19:28 UTC |
ALAM JOHN JSVP, Drug Eval. & Appr.
|
Exercise / conversionStock Options · Derivative | 500 | $0.00 Strike: $9.07 | $0.00 |
DisclosureSEC source: 0000875320-06-000124 · edgar.xml · derivative · entry 7 ALAM JOHN J · CIK 0001197014 · SVP, Drug Eval. & Appr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 499,995 Underlying: Common Stock · 500 shares Expires 2013-12-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting quarterly over 4 years from 12/11/2003. Read SEC document |
| December 20, 2006 Filed Dec 21, 2006 19:28 UTC |
ALAM JOHN JSVP, Drug Eval. & Appr.
|
Exercise / conversionStock Options · Derivative | 1,000 | $0.00 Strike: $18.47 | $0.00 |
DisclosureSEC source: 0000875320-06-000124 · edgar.xml · derivative · entry 6 ALAM JOHN J · CIK 0001197014 · SVP, Drug Eval. & Appr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,495 Underlying: Common Stock · 1,000 shares Expires 2007-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting quarterly over 5 years from 9/26/1997. Read SEC document |
| December 20, 2006 Filed Dec 21, 2006 19:28 UTC |
ALAM JOHN JSVP, Drug Eval. & Appr.
|
SaleCommon Stock | 500 | $37.78 | $18,890.00 |
DisclosureSEC source: 0000875320-06-000124 · edgar.xml · nonDerivative · entry 4 ALAM JOHN J · CIK 0001197014 · SVP, Drug Eval. & Appr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,376 F1 · kind: Transaction made pursuant to Dr. Alam's company approved trading plan established under rule 10b5-1. Read SEC document |
| December 20, 2006 Filed Dec 21, 2006 19:28 UTC |
ALAM JOHN JSVP, Drug Eval. & Appr.
|
SaleCommon Stock | 1,000 | $37.78 | $37,780.00 |
DisclosureSEC source: 0000875320-06-000124 · edgar.xml · nonDerivative · entry 3 ALAM JOHN J · CIK 0001197014 · SVP, Drug Eval. & Appr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,876 F1 · kind: Transaction made pursuant to Dr. Alam's company approved trading plan established under rule 10b5-1. Read SEC document |
| December 20, 2006 Filed Dec 21, 2006 19:28 UTC |
ALAM JOHN JSVP, Drug Eval. & Appr.
|
Exercise / conversionCommon Stock | 500 | $9.07 | $4,535.00 |
DisclosureSEC source: 0000875320-06-000124 · edgar.xml · nonDerivative · entry 2 ALAM JOHN J · CIK 0001197014 · SVP, Drug Eval. & Appr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,876 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2006 Filed Dec 21, 2006 19:28 UTC |
ALAM JOHN JSVP, Drug Eval. & Appr.
|
Exercise / conversionCommon Stock | 1,000 | $18.47 | $18,470.00 |
DisclosureSEC source: 0000875320-06-000124 · edgar.xml · nonDerivative · entry 1 ALAM JOHN J · CIK 0001197014 · SVP, Drug Eval. & Appr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,376 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 19, 2006 Filed Dec 20, 2006 17:55 UTC |
MUELLER PETERCSO&EVP Drug Innov&Realization
|
SaleCommon Stock | 165 | $38.00 | $6,270.00 |
DisclosureSEC source: 0000875320-06-000123 · edgar.xml · nonDerivative · entry 1 MUELLER PETER · CIK 0001256126 · CSO&EVP Drug Innov&Realization 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,747 F1 · kind: Transaction made pursuant to Dr. Mueller's company approved trading plan established under Rule 10b5-1. Read SEC document |
| December 18, 2006 Filed Dec 19, 2006 16:44 UTC |
POWER JOHANNA MESSINAVP & Controller
|
Exercise / conversionCommon Stock · Derivative | 125 | $0.00 Strike: $9.69 | $0.00 |
DisclosureSEC source: 0000875320-06-000122 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,585 Underlying: Common Stock · 125 shares Expires 2014-03-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 20 equal quarterly installments from 3/17/2004. Read SEC document |
| December 18, 2006 Filed Dec 19, 2006 16:44 UTC |
POWER JOHANNA MESSINAVP & Controller
|
SaleCommon Stock | 125 | $38.94 | $4,867.50 |
DisclosureSEC source: 0000875320-06-000122 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,287 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| December 18, 2006 Filed Dec 19, 2006 16:44 UTC |
POWER JOHANNA MESSINAVP & Controller
|
Exercise / conversionCommon Stock | 125 | $9.69 | $1,211.25 |
DisclosureSEC source: 0000875320-06-000122 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,412 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2006 Filed Dec 18, 2006 21:49 UTC |
SANDERS CHARLES ADirector
|
GrantStock Option · Derivative | 20,000 | $0.00 Strike: $38.95 | $0.00 |
DisclosureSEC source: 0000875320-06-000121 · edgar.xml · derivative · entry 1 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 20,000 shares Expires 2016-12-14 F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan. Fully vested. Read SEC document |
| December 14, 2006 Filed Dec 15, 2006 16:29 UTC |
COLLINSON STUART JDirector
|
Exercise / conversionStock Option · Derivative | 420 | $0.00 Strike: $9.68 | $0.00 |
DisclosureSEC source: 0000875320-06-000119 · edgar.xml · derivative · entry 5 COLLINSON STUART J · CIK 0001197037 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,104 Underlying: Common Stock · 420 shares Expires 2009-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Right to buy under the 1996 Stock and Option Plan, fully vested as of 4/29/1999. Read SEC document |
| December 14, 2006 Filed Dec 15, 2006 16:29 UTC |
COLLINSON STUART JDirector
|
Exercise / conversionStock Option · Derivative | 49,599 | $0.00 Strike: $18.25 | $0.00 |
DisclosureSEC source: 0000875320-06-000119 · edgar.xml · derivative · entry 4 COLLINSON STUART J · CIK 0001197037 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,524 Underlying: Common Stock · 49,599 shares Expires 2009-12-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under the 1996 Stock and Option Plan, fully vested as of 12/7/1999. Read SEC document |
| December 14, 2006 Filed Dec 15, 2006 16:29 UTC |
COLLINSON STUART JDirector
|
SaleCommon Stock | 50,019 | $37.81 | $1,891,218.39 |
DisclosureSEC source: 0000875320-06-000119 · edgar.xml · nonDerivative · entry 3 COLLINSON STUART J · CIK 0001197037 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,279 F1 · kind: Transaction made pursuant to Dr. Collinson's company approved trading plan established under Rule 10b5-1. Read SEC document |
| December 14, 2006 Filed Dec 15, 2006 16:29 UTC |
COLLINSON STUART JDirector
|
Exercise / conversionCommon Stock | 420 | $9.68 | $4,065.60 |
DisclosureSEC source: 0000875320-06-000119 · edgar.xml · nonDerivative · entry 2 COLLINSON STUART J · CIK 0001197037 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,298 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 14, 2006 Filed Dec 15, 2006 16:29 UTC |
COLLINSON STUART JDirector
|
Exercise / conversionCommon Stock | 49,599 | $18.25 | $905,181.75 |
DisclosureSEC source: 0000875320-06-000119 · edgar.xml · nonDerivative · entry 1 COLLINSON STUART J · CIK 0001197037 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,878 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2006 Filed Dec 14, 2006 15:31 UTC |
POWER JOHANNA MESSINAVP & Controller
|
SaleCommon Stock | 10 | $38.76 | $387.60 |
DisclosureSEC source: 0000875320-06-000116 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,287 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| December 13, 2006 Filed Dec 14, 2006 15:34 UTC |
SMITH IAN FEVP & CFO
|
SaleCommon Stock | 480 | $38.55 | $18,504.00 |
DisclosureSEC source: 0000875320-06-000117 · edgar.xml · nonDerivative · entry 1 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,530 F1 · kind: Transaction made pursuant to Mr. Smith's company approved trading plan established under Rule 10b5-1. Read SEC document |
| December 13, 2006 Filed Dec 14, 2006 15:36 UTC |
ALAM JOHN JEVP, Medicines Dev. & CMO
|
SaleCommon Stock | 480 | $38.85 | $18,648.00 |
DisclosureSEC source: 0000875320-06-000118 · edgar.xml · nonDerivative · entry 2 ALAM JOHN J · CIK 0001197014 · EVP, Medicines Dev. & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,876 F1 · kind: Transaction made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1. Read SEC document |
| December 13, 2006 Filed Dec 14, 2006 15:36 UTC |
ALAM JOHN JEVP, Medicines Dev. & CMO
|
SaleCommon Stock | 1,500 | $38.54 | $57,810.00 |
DisclosureSEC source: 0000875320-06-000118 · edgar.xml · nonDerivative · entry 1 ALAM JOHN J · CIK 0001197014 · EVP, Medicines Dev. & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,356 F1 · kind: Transaction made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1. Read SEC document |
| December 13, 2006 Filed Dec 15, 2006 16:31 UTC Amendment |
ALAM JOHN JEVP, Medicines Dev. & CMO
|
Exercise / conversionStock Option · Derivative | 500 | $0.00 Strike: $9.07 | $0.00 |
DisclosureSEC source: 0000875320-06-000120 · edgar.xml · derivative · entry 7 ALAM JOHN J · CIK 0001197014 · EVP, Medicines Dev. & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 501,495 Underlying: Common Stock · 500 shares Expires 2013-12-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting quarterly over 4 years from 12/11/2003. Read SEC document |
| December 13, 2006 Filed Dec 15, 2006 16:31 UTC Amendment |
ALAM JOHN JEVP, Medicines Dev. & CMO
|
Exercise / conversionStock Option · Derivative | 1,000 | $0.00 Strike: $18.47 | $0.00 |
DisclosureSEC source: 0000875320-06-000120 · edgar.xml · derivative · entry 6 ALAM JOHN J · CIK 0001197014 · EVP, Medicines Dev. & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 501,995 Underlying: Common Stock · 1,000 shares Expires 2007-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting quarterly over 5 ;years from 9/26/1997. Read SEC document |
| December 13, 2006 Filed Dec 15, 2006 16:31 UTC Amendment |
ALAM JOHN JEVP, Medicines Dev. & CMO
|
SaleCommon Stock | 480 | $38.85 | $18,648.00 |
DisclosureSEC source: 0000875320-06-000120 · edgar.xml · nonDerivative · entry 4 ALAM JOHN J · CIK 0001197014 · EVP, Medicines Dev. & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,376 F1 · kind: Transaction made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1. Read SEC document |
| December 13, 2006 Filed Dec 15, 2006 16:31 UTC Amendment |
ALAM JOHN JEVP, Medicines Dev. & CMO
|
SaleCommon Stock | 1,500 | $38.54 | $57,810.00 |
DisclosureSEC source: 0000875320-06-000120 · edgar.xml · nonDerivative · entry 3 ALAM JOHN J · CIK 0001197014 · EVP, Medicines Dev. & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,856 F1 · kind: Transaction made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1. Read SEC document |
| December 13, 2006 Filed Dec 15, 2006 16:31 UTC Amendment |
ALAM JOHN JEVP, Medicines Dev. & CMO
|
Exercise / conversionCommon Stock | 500 | $9.07 | $4,535.00 |
DisclosureSEC source: 0000875320-06-000120 · edgar.xml · nonDerivative · entry 2 ALAM JOHN J · CIK 0001197014 · EVP, Medicines Dev. & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,356 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2006 Filed Dec 15, 2006 16:31 UTC Amendment |
ALAM JOHN JEVP, Medicines Dev. & CMO
|
Exercise / conversionCommon Stock | 1,000 | $18.47 | $18,470.00 |
DisclosureSEC source: 0000875320-06-000120 · edgar.xml · nonDerivative · entry 1 ALAM JOHN J · CIK 0001197014 · EVP, Medicines Dev. & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,856 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2006 Filed Dec 12, 2006 15:46 UTC |
POWER JOHANNA MESSINAVP & Controller
|
Exercise / conversionCommon Stock · Derivative | 250 | $0.00 Strike: $9.69 | $0.00 |
DisclosureSEC source: 0000875320-06-000115 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,710 Underlying: Common Stock · 250 shares Expires 2014-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 20 equal quarterly installments from 3/17/2004. Read SEC document |
| December 11, 2006 Filed Dec 12, 2006 15:46 UTC |
POWER JOHANNA MESSINAVP & Controller
|
SaleCommon Stock | 250 | $40.98 | $10,245.00 |
DisclosureSEC source: 0000875320-06-000115 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,297 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| December 11, 2006 Filed Dec 12, 2006 15:46 UTC |
POWER JOHANNA MESSINAVP & Controller
|
Exercise / conversionCommon Stock | 250 | $9.69 | $2,422.50 |
DisclosureSEC source: 0000875320-06-000115 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,547 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 08, 2006 Filed Dec 11, 2006 16:46 UTC |
SANDERS CHARLES ADirector
|
Exercise / conversionStock Option · Derivative | 2,000 | $0.00 Strike: $13.23 | $0.00 |
DisclosureSEC source: 0000875320-06-000114 · edgar.xml · derivative · entry 6 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 2,000 shares Expires 2006-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1994 Stock and Option Plan. Fully vested. Read SEC document |
| December 08, 2006 Filed Dec 11, 2006 16:46 UTC |
SANDERS CHARLES ADirector
|
SaleCommon Stock | 2,000 | $42.95 | $85,900.00 |
DisclosureSEC source: 0000875320-06-000114 · edgar.xml · nonDerivative · entry 4 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,000 F1 · kind: Transaction made pursuant to Dr. Sanders' company approved trading plan established under Rule 10b5-1. Read SEC document |
| December 08, 2006 Filed Dec 11, 2006 16:46 UTC |
SANDERS CHARLES ADirector
|
Exercise / conversionCommon Stock | 2,000 | $13.23 | $26,460.00 |
DisclosureSEC source: 0000875320-06-000114 · edgar.xml · nonDerivative · entry 3 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 07, 2006 Filed Dec 11, 2006 16:46 UTC |
SANDERS CHARLES ADirector
|
Exercise / conversionStock Option · Derivative | 3,000 | $0.00 Strike: $13.23 | $0.00 |
DisclosureSEC source: 0000875320-06-000114 · edgar.xml · derivative · entry 5 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,000 Underlying: Common Stock · 3,000 shares Expires 2006-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1994 Stock and Option Plan. Fully vested. Read SEC document |
| December 07, 2006 Filed Dec 11, 2006 16:46 UTC |
SANDERS CHARLES ADirector
|
SaleCommon Stock | 3,000 | $43.97 | $131,910.00 |
DisclosureSEC source: 0000875320-06-000114 · edgar.xml · nonDerivative · entry 2 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,000 F1 · kind: Transaction made pursuant to Dr. Sanders' company approved trading plan established under Rule 10b5-1. Read SEC document |
| December 07, 2006 Filed Dec 11, 2006 16:46 UTC |
SANDERS CHARLES ADirector
|
Exercise / conversionComon Stock | 3,000 | $13.23 | $39,690.00 |
DisclosureSEC source: 0000875320-06-000114 · edgar.xml · nonDerivative · entry 1 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 06, 2006 Filed Dec 7, 2006 17:56 UTC |
ALAM JOHN JEVP, Medicines Dev. & CMO
|
Exercise / conversionStock Option · Derivative | 500 | $0.00 Strike: $9.07 | $0.00 |
DisclosureSEC source: 0000875320-06-000112 · edgar.xml · derivative · entry 6 ALAM JOHN J · CIK 0001197014 · EVP, Medicines Dev. & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 502,995 Underlying: Common Stock · 500 shares Expires 2013-12-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting quarterly over 4 years from 12/11/2003. Read SEC document |
| December 06, 2006 Filed Dec 7, 2006 17:56 UTC |
ALAM JOHN JEVP, Medicines Dev. & CMO
|
Exercise / conversionStock Option · Derivative | 1,000 | $0.00 Strike: $18.47 | $0.00 |
DisclosureSEC source: 0000875320-06-000112 · edgar.xml · derivative · entry 5 ALAM JOHN J · CIK 0001197014 · EVP, Medicines Dev. & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 503,495 Underlying: Common Stock · 1,000 shares Expires 2007-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting quarterly over 5 years from 9/26/1997. Read SEC document |
| December 06, 2006 Filed Dec 7, 2006 17:56 UTC |
ALAM JOHN JEVP, Medicines Dev. & CMO
|
SaleCommon Stock | 1,500 | $44.69 | $67,035.00 |
DisclosureSEC source: 0000875320-06-000112 · edgar.xml · nonDerivative · entry 3 ALAM JOHN J · CIK 0001197014 · EVP, Medicines Dev. & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,856 F1 · kind: Transaction made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1. Read SEC document |
| December 06, 2006 Filed Dec 7, 2006 17:56 UTC |
ALAM JOHN JEVP, Medicines Dev. & CMO
|
Exercise / conversionCommon Stock | 500 | $9.07 | $4,535.00 |
DisclosureSEC source: 0000875320-06-000112 · edgar.xml · nonDerivative · entry 2 ALAM JOHN J · CIK 0001197014 · EVP, Medicines Dev. & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,356 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 06, 2006 Filed Dec 7, 2006 17:56 UTC |
ALAM JOHN JEVP, Medicines Dev. & CMO
|
Exercise / conversionCommon Stock | 1,000 | $18.47 | $18,470.00 |
DisclosureSEC source: 0000875320-06-000112 · edgar.xml · nonDerivative · entry 1 ALAM JOHN J · CIK 0001197014 · EVP, Medicines Dev. & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,856 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.